Chapter 1 INTRODUCTION

Chapter 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.1. CXO PERSPECTIVE

Chapter 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top wining strategies

3.2.1.1. Competitive intelligence of companies and their strategies

3.2.2. Top investment pockets

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Improved Immunization Coverage
3.3.1.2. Eliminate Risks of Needles
3.3.1.3. Reduce Health Care Costs
3.3.1.4. Increasing patient power

3.3.2. Restrains

3.3.2.1. Dearth of trained personnel
3.3.2.2. Limitation in intravenous administration

3.3.3. Opportunities

3.3.3.1. Wider range of applications
3.3.3.2. Technological advancements

3.3.4. Impact analysis

3.4. MARKET SHARE ANALYSIS, 2016
3.5. GOVERNMENT REGULATIONS
3.6. CLINICAL TRIALS

Chapter 4 NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. FILLABLE NEEDLE-FREE INJECTORS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. PREFILLED NEEDLE-FREE INJECTORS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter 5 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SOURCE OF POWER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. SPRING-BASED NEEDLE-FREE INJECTORS

5.2.1. Market size and forecast

5.3. GAS PROPELLED/ AIR FORCED INJECTOR SYSTEMS

5.3.1. Market size and forecast

Chapter 6 NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. LIQUID-BASED NEEDLE FREE INJECTORS

6.2.1. Market size and Forecast

6.3. PROJECTILE/DEPOT-BASED NEEDLE-FREE INJECTORS

6.3.1. Market size and forecast

6.4. POWDER-BASED NEEDLE FREE INJECTORS

6.4.1. Market size and forecast

Chapter 7 NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. SUBCUTANEOUS INJECTORS

7.2.1. Market size and forecast

7.3. INTRAMUSCULAR INJECTORS

7.3.1. Market size and forecast

7.4. INTRADERMAL INJECTORS

7.4.1. Market size and forecast

Chapter 8 NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. DISPOSABLE NEEDLE-FREE INJECTORS

8.2.1. Market size and forecast

8.3. REUSABLE NEEDLE-FREE INJECTORS

8.3.1. Market size and forecast

Chapter 9 NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION

9.1. OVERVIEW

9.1.1. Market size and forecast

9.2. VACCINE DELIVERY

9.2.1. Market size and forecast

9.3. INSULIN DELIVERY

9.3.1. Market size and forecast

9.4. PAIN MANAGEMENT

9.4.1. Main size and forecast

9.5. OTHER APPLICATIONS

9.5.1. Market size and forecast

Chapter 10 NEEDLE-FREE INJECTION SYSTEM MARKET, BY END-USER

10.1. OVERVIEW

10.1.1. Market size and forecast

10.2. HOSPITALS AND CLINICS

10.2.1. Market size and forecast

10.3. HOME CARE SETTINGS

10.3.1. Market size and forecast

10.4. RESEARCH LABORATORIES

10.4.1. Market size and forecast

10.5. OTHER END USERS

10.5.1. Market size and forecast

Chapter 11 NEEDLE-FREE INJECTION SYSTEM MARKET, BY REGION

11.1. OVERVIEW

11.1.1. Market size and forecast

11.2. NORTH AMERICA

11.2.1. Key market trends
11.2.2. Growth factors and opportunities
11.2.3. Market size and forecast

11.2.3.1. U.S. market size and forecast
11.2.3.2. Canada market size and forecast
11.2.3.3. Mexico market size and forecast

11.3. EUROPE

11.3.1. Key market trends
11.3.2. Growth factors and opportunities
11.3.3. Market size and forecast

11.3.3.1. Germany market size and forecast
11.3.3.2. France market size and forecast
11.3.3.3. UK market size and forecast
11.3.3.4. Italy market size and forecast
11.3.3.5. Spain market size and forecast
11.3.3.6. Rest of Europe market size and forecast

11.4. ASIA-PACIFIC

11.4.1. Key market trends
11.4.2. Growth factors and opportunities
11.4.3. Market size and forecast

11.4.3.1. Japan market size and forecast
11.4.3.2. China market size and forecast
11.4.3.3. India market size and forecast
11.4.3.4. Australia market size and forecast
11.4.3.5. Rest of Asia-Pacific market size and forecast

11.5. LAMEA

11.5.1. Key market trends
11.5.2. Growth factors and opportunities
11.5.3. Market size and forecast

11.5.3.1. Brazil market size and forecast
11.5.3.2. South Africa market size and forecast
11.5.3.3. Saudi Arabia market size and forecast
11.5.3.4. Rest of LAMEA market size and forecast

Chapter 12 COMPANY PROFILES

12.1. ANTARES PHARMA, INC.

12.1.1. Company overview
12.1.2. Operating business segments
12.1.3. Business performance
12.1.4. Key strategic moves and developments

12.2. MEDICAL INTERNATIONAL TECHNOLOGY, INC.

12.2.1. Company overview
12.2.2. Operating business segments
12.2.3. Business performance
12.2.4. Key strategic moves and developments

12.3. INJEX PHARMA AG

12.3.1. Company overview
12.3.2. Operating business segments
12.3.3. Business performance
12.3.4. Key strategic moves and developments

12.4. NATIONAL MEDICAL PRODUCTS INC.

12.4.1. Company overview
12.4.2. Operating business segments
12.4.3. Business performance
12.4.4. Key strategic moves and developments

12.5. EUROPEAN PHARMA GROUP

12.5.1. Company overview
12.5.2. Operating business segments
12.5.3. Business performance
12.5.4. Key strategic moves and developments

12.6. VALERITAS, INC.

12.6.1. Company overview
12.6.2. Operating business segments
12.6.3. Business performance
12.6.4. Key strategic moves and developments

12.7. PHARMAJET

12.7.1. Company overview
12.7.2. Operating business segments
12.7.3. Business performance
12.7.4. Key strategic moves and developments

12.8. PENJET CORPORATION

12.8.1. Company overview
12.8.2. Operating business segments
12.8.3. Business performance
12.8.4. Key strategic moves and developments

12.9. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS

12.9.1. Company overview
12.9.2. Operating business segments
12.9.3. Business performance
12.9.4. Key strategic moves and developments